[1] Paulo D, Semonche A, Choudhry O, Al-Mufti F, Prestigiacomo CJ, Roychowdhury S, et al. History of hemostasis in neurosurgery. World Neurosurg 2019;124:237–50.
[2] Giammalva GR, Brunasso L, Costanzo R, Paolini S, Umana G, Yağmurlu K, Chaurasia B, Cicero S, Scalia G, Basile L, Gerardi RM. The role of hemostatic devices in neurosurgery. A systematic review. Journal of Clinical Neuroscience.2021 Jul 1;89:151-7.
[3] Dujovny M, Dujovny N, Gundamraj NR, Misra M. Bipolar coagulation in neurosurgery. Surgical neurology. 1998 Mar 1;49(3):328-32.
[4] Abramson DH, Andracchi S. Orbital avitene granuloma formation after enucleation for intraocular retinoblastoma. Am J Ophthalmol 1997;123:567–9.
[5] Giammalva G, Iacopino D, Maugeri R. Natura abhorret a vacuo. Future perspectives of autologous fibrin glue. Is it time for reappraisal?. SurgNeurol Int 2017;8:57.
[6] Lin, B.; Yang, H.; Cui, M.; Li, Y.; Yu, J. SurgicelTM application in intracranial hemorrhage surgery contributed to giant-cell granuloma in a patient with hypertension: Case report and review of the literature. World J. Surg. Oncol. 2014, 12, 10.1186/1477-7819-12-101.
[7] Landi A, Gregori F, Marotta N, Delfini R. Security, and manageability of gelified hemostatic matrix in bleeding control during thoracic and lumbar spine surgery: FloSeal versus Surgiflo. J Neurol Surgery, Part A Cent Eur Neurosurg 2015;77:139–43.
[8] Ng W, Jerath A, Wasowicz M. Tranexamic acid: a clinical review. Anaesthesiol Intensive Ther 2015;47:339–50.
[9] Menovsky T, Plazier M, Rasschaert R, Maas AIR, Parizel PM, Verbeke S. Massive swelling of Surgicel FibrillarTM hemostat after spinal surgerycase report and a review of the literature. Minim Invasive Neurosurg 2011;54:257–9.
[10] Zhou H, Ge J, Bai Y, Liang C, Yang L. Translation of bone wax and its substitutes:History, clinical status and future directions. J Orthop Transl 2019;17:64–72.
[11] Kamide T, Nakada M, Hirota Y, Hayashi Y, Hayashi Y, Uchiyama N, et al. Skull osteohypertrophy as a complication of bone wax. J Clin Neurosci 2009;16:1658–60.
[12] Ozdol C, Alagoz F, Yildirim AE, Korkmaz M, Daglioglu E, Atilla P, et al. Use of SpongostanTM for prevention of cranial subdural adhesions following craniotomy in an experimental rabbit model. Turk Neurosurg 2015;25:707–11.
[13] Ismailoglu O, Kizilay Z, Kahraman Cetin N, Topcu A, Berber O. Effect of curcumin on the formation of epidural fibrosis in an experimental laminectomy model in rats. Turk Neurosurg 2019;29:440-4.
[14] Librianto D, Saleh I. Gelatin sponge as a rare and forgotten cause of early-onset neurological deficit post osteotomy of thoracolumbar kyphosis—A case report and review of literature. International Journal of Surgery Case Reports. 2020 Jan 1;75:497-503.
[15] Elieh-Ali-Komi D, Hamblin MR. Chitin and chitosan: production and application of versatile biomedical nanomaterials. International journal of advanced research. 2016 Mar;4(3):411.
[16] Islam S, Bhuiyan MR, Islam MN. Chitin and chitosan: structure, properties and applications in biomedical engineering. Journal of Polymers and the Environment. 2017 Sep;25:854-66.
[17] Anitha A, Sowmya S, Kumar PS, Deepthi S, Chennazhi KP, Ehrlich H, Tsurkan M, Jayakumar R. Chitin and chitosan in selected biomedical applications. Progress in polymer science. 2014 Sep 1;39(9):1644-67.
[18] Ibrahim MA, Alhalafi MH, Emam EA, Ibrahim H, Mosaad RM. A review of chitosan and chitosan nanofiber: Preparation, characterization, and its potential applications. Polymers. 2023 Jun 26;15(13):2820.
[19] Ramya R, Venkatesan J, Kim SK, Sudha PN. Biomedical applications of chitosan: an overview. Journal of Biomaterials and Tissue Engineering. 2012 Jun 1;2(2):100-11.
[20] Pogorielov MV, Sikora VZ. Chitosan as a hemostatic agent: current state. European Journal of Medicine. Series B. 2015(1):24-33.
[21] Gheorghiță D, Moldovan H, Robu A, Bița AI, Grosu E, Antoniac A, Corneschi I, Antoniac I, Bodog AD, Băcilă CI. Chitosan-Based Biomaterials for Hemostatic Applications: A Review of Recent Advances. International journal of molecular sciences. 2023 Jun 23;24(13):10540.
[22] Khan MA, Mujahid M. A review on recent advances in chitosan based composite for hemostatic dressings. International journal of biological macromolecules. 2019 Mar 1;124:138-47.
[23] Lih E, Lee JS, Park KM, Park KD. Rapidly curable chitosan–PEG hydrogels as tissue adhesives for hemostasis and wound healing. Acta biomaterialia. 2012 Sep 1;8(9):3261-9.
[24] Sabab A, Vreugde S, Jukes A, Wormald PJ. The potential of chitosan-based haemostats for use in neurosurgical setting–Literature review. Journal of Clinical Neuroscience. 2021 Dec 1;94:128-34.
[25] Brandenberg G et al. Chitosan: a new topical hemostatic agent for diffuse capillary bleeding in brain tissue. Neurosurgery 1984;15(1):9–13.
[26] Sandoval-Sanchez JH et al. A new bilayer chitosan scaffolding as a dural substitute: experimental evaluation. World Neurosurg 2012;77(3–4):577–82.
[27] Pogorielov M et al. Experimental evaluation of new chitin-chitosan graft for duraplasty. J Mater Sci Mater Med 2017;28(2):34.
[28] Rajiv S, Harding M, Bassiouni A, Jardeleza C, Drilling A, James C, Ha T, Moratti S, Robinson S, Wormald PJ. The efficacy and safety of chitosan dextran gel in a burr hole neurosurgical sheep model. Acta neurochirurgica. 2013 Jul;155:1361-6.
[29] Crofton A, Chrisler J, Hudson S, Inceoglu S, Petersen F, Kirsch W. Effect of plasma sterilization on the hemostatic efficacy of a chitosan hemostatic agent in a rat model. Advances in Therapy. 2016 Feb;33:268-81.
[30] Ereth MH, Schaff M, Ericson EF, Wetjen NM, Nuttall GA, Oliver Jr WC. Comparative safety and efficacy of topical hemostatic agents in a rat neurosurgical model. Operative Neurosurgery. 2008 Oct 1;63(4):369-72.
Pathobiology Reserach